Literature DB >> 11779142

Inhibitors of fibril formation and cytotoxicity of beta-amyloid peptide composed of KLVFF recognition element and flexible hydrophilic disrupting element.

Ken-ichi Watanabe1, Kazuhiko Nakamura, Shingo Akikusa, Tomoko Okada, Masato Kodaka, Takeo Konakahara, Hiroaki Okuno.   

Abstract

Beta-Amyloid peptide (Abeta) is the main protein components of neuritic plaques and its neurotoxicity would be exposed by formation of aggregate. The aggregation inhibitors composed of an Abeta recognition element (KLVFF) and a flexible hydrophilic disrupting element (aminoethoxy ethoxy acetate and aspartate) are designed and chemically synthesized. The inhibitory effects are examined by a pigment binding assay using Congo red or thioflavin T. The present compounds suppress the formation of aggregate, and the compound DDX3 is an especially effective inhibitor. In addition, the synthesized compounds efficiently suppress the cytotoxicity of Abeta against IMR-32 neuroblastoma cells in vitro. (c)2002 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11779142     DOI: 10.1006/bbrc.2001.6191

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Structure-activity relationships in peptide modulators of β-amyloid protein aggregation: variation in α,α-disubstitution results in altered aggregate size and morphology.

Authors:  Cyrus K Bett; Johnpeter N Ngunjiri; Wilson K Serem; Krystal R Fontenot; Robert P Hammer; Robin L McCarley; Jayne C Garno
Journal:  ACS Chem Neurosci       Date:  2010-07-08       Impact factor: 4.418

2.  Rationally designed peptoids modulate aggregation of amyloid-beta 40.

Authors:  J Phillip Turner; Tammy Lutz-Rechtin; Kelly A Moore; Lauren Rogers; Omkar Bhave; Melissa A Moss; Shannon L Servoss
Journal:  ACS Chem Neurosci       Date:  2014-04-16       Impact factor: 4.418

3.  Nanoparticle-chelator conjugates as inhibitors of amyloid-beta aggregation and neurotoxicity: a novel therapeutic approach for Alzheimer disease.

Authors:  Gang Liu; Ping Men; Wataru Kudo; George Perry; Mark A Smith
Journal:  Neurosci Lett       Date:  2009-03-25       Impact factor: 3.046

4.  Kinetic studies of inhibition of the amyloid beta (1-42) aggregation using a ferrocene-tagged β-sheet breaker peptide.

Authors:  Lin Zhang; Gargey Yagnik; Yong Peng; Jianxiu Wang; H Howard Xu; Yuanqiang Hao; You-Nian Liu; Feimeng Zhou
Journal:  Anal Biochem       Date:  2012-12-08       Impact factor: 3.365

5.  Self-assembly of a nine-residue amyloid-forming peptide fragment of SARS corona virus E-protein: mechanism of self aggregation and amyloid-inhibition of hIAPP.

Authors:  Anirban Ghosh; Amit S Pithadia; Jyotsna Bhat; Supriyo Bera; Anupam Midya; Carol A Fierke; Ayyalusamy Ramamoorthy; Anirban Bhunia
Journal:  Biochemistry       Date:  2015-03-24       Impact factor: 3.162

6.  Inhibition of amyloid fibrillogenesis and toxicity by a peptide chaperone.

Authors:  Puttur Santhoshkumar; Krishna K Sharma
Journal:  Mol Cell Biochem       Date:  2004-12       Impact factor: 3.396

7.  Chemical probes that selectively recognize the earliest Aβ oligomers in complex mixtures.

Authors:  Ashley A Reinke; Peter M U Ung; Jerome J Quintero; Heather A Carlson; Jason E Gestwicki
Journal:  J Am Chem Soc       Date:  2010-11-24       Impact factor: 15.419

8.  Multivalent Polymer-Peptide Conjugates-A General Platform for Inhibiting Amyloid Beta Peptide Aggregation.

Authors:  Xing Jiang; Abigail J Halmes; Giuseppe Licari; John W Smith; Yang Song; Edwin G Moore; Qian Chen; Emad Tajkhorshid; Chad M Rienstra; Jeffrey S Moore
Journal:  ACS Macro Lett       Date:  2019-09-30       Impact factor: 6.903

9.  New insights into the mechanism of Alzheimer amyloid-beta fibrillogenesis inhibition by N-methylated peptides.

Authors:  Patricia Soto; Mary A Griffin; Joan-Emma Shea
Journal:  Biophys J       Date:  2007-07-13       Impact factor: 4.033

10.  Molecular dynamics studies of alpha-helix stability in fibril-forming peptides.

Authors:  Erik Nordling; Yvonne Kallberg; Jan Johansson; Bengt Persson
Journal:  J Comput Aided Mol Des       Date:  2007-12-06       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.